Oric Pharmaceuticals

ORIC

Valor de mercado US$ 914 mi

#	Nome	Posição	Valor negociado	Ações Variação	Variação na participação
1	1 Nextech Invest Zurich, Switzerland	US$ 86 mi	–	–	–
2	2 EcoR1 Capital San Francisco, California	US$ 80,7 mi	+US$ 53,8 mi	+5.110.048	+316%
3	3 VR Adviser New York	US$ 79,2 mi	–	–	–
4	4 Viking Global Investors Stamford, Connecticut	US$ 78,9 mi	–	–	–
5	5 Pfizer New York	US$ 64,5 mi	–	–	–
6	6 BlackRock New York	US$ 63,3 mi	+US$ 12,6 mi	+1.198.635	+29%
7	7 Vanguard Group Malvern, Pennsylvania	US$ 55,8 mi	+US$ 16 mi	+1.525.445	+49%
8	8 SR One Capital Management Wayne, Pennsylvania	US$ 54,2 mi	–	–	–
9	9 Alkeon Capital Management New York	US$ 54 mi	–	–	–
10	10 NEA Management Company Timonium, Maryland	US$ 49,4 mi	–	–	–
11	11 OrbiMed New York	US$ 43,7 mi	+US$ 28,9 mi	+2.742.475	+305%
12	12 Column Group San Francisco, California	US$ 42,5 mi	–	–	–
13	13 Vivo Capital Palo Alto, California	US$ 37,5 mi	–	–	–
14	14 T. Rowe Price Associates Baltimore, Maryland	US$ 34,5 mi	+US$ 1,14 mi	+108.412	+4%
15	15 Point72 Asset Management Stamford, Connecticut	US$ 31,4 mi	-US$ 2,43 mi	-230.727	-8%
16	16 Fidelity Investments Boston, Massachusetts	US$ 30,3 mi	+US$ 610 mil	+57.991	+2%
17	17 State Street Boston, Massachusetts	US$ 28,8 mi	+US$ 8,12 mi	+771.823	+47%
18	18 First Turn Management Del Mar, California	US$ 25,9 mi	+US$ 1,57 mi	+149.551	+7%
19	19 Silverarc Capital Management Boston, Massachusetts	US$ 23,4 mi	+US$ 1,56 mi	+147.979	+8%
20	20 MPM BioImpact Boston, Massachusetts	US$ 20,8 mi	–	–	–
21	21 Geode Capital Management Boston, Massachusetts	US$ 19,6 mi	+US$ 5,49 mi	+522.284	+47%
22	22 Balyasny Asset Management Chicago, Illinois	US$ 18,2 mi	-US$ 2,72 mi	-258.430	-15%
23	23 Royce & Associates New York	US$ 17,5 mi	+US$ 12,9 mi	+1.223.709	+521%
24	24 JP Morgan Chase New York	US$ 14,7 mi	-US$ 1,12 mi	-106.920	-8%
25	25 Citadel Advisors Miami, Florida	US$ 14,4 mi	-US$ 2,15 mi	-204.764	-15%

Oric Pharmaceuticals ORIC Valor de mercado US$ 914 mi

Oric Pharmaceuticals

ORIC

Valor de mercado US$ 914 mi